CooperCompanies (COO) Reports Q1: Everything You Need To Know Ahead Of Earnings
CooperCompanies (COO) is set to report Q1 earnings Thursday after the bell. The company reported Q1 revenue of $1.02B, up 6.2% year over year, and met revenue expectations; it beat full-year EPS guidance, with organic revenue in line. For Q1, analysts expect 5.1% revenue growth. CooperCompanies shares are down 3.3% over a month; the average analyst price target is $88.21 vs. $59.50.
How this was made
The 30-second read
Why it matters
The key trading question is whether COO can avoid another revenue miss while maintaining the EPS/guidance momentum that previously beat estimates; peer outperformance may raise the bar for diversified medical devices demand.
Market read
Pre-earnings positioning for COO is shaped by consensus slowdown, recent revenue-miss risk, and supportive peer prints in diversified medical devices.
What to watch
The article flags revenue-miss history and organic revenue in-line; traders may also need to watch management commentary for whether the 5.1% growth outlook is sustainable given the prior 6.3% pace.
Background
Yahoo frames COO’s upcoming earnings with last quarter’s results (revenue $1.02B, +6.2% YoY) and consensus expectations for Q1 revenue growth to slow to 5.1% YoY.
Ticker impact
CooperCompanies is set to report Q1 earnings after the bell, with revenue/EPS expectations and guidance-beat framing driving pre-print positioning.
High two-sided volatility risk into the after-hours print; direction likely hinges on organic revenue vs expectations and any commentary on growth deceleration.
The article provides consensus growth expectations, notes recent revenue estimate misses, and highlights a prior EPS guidance beat—key drivers of earnings-surprise repricing.
Market effects
Peer prints (Baxter, Boston Scientific) are used as read-across, potentially shaping how traders underwrite diversified medical devices demand into COO’s results.
Primarily US-listed sentiment; no specific regional catalyst beyond US earnings season positioning.
Limited—article focuses on US earnings expectations and peer read-through rather than global macro/regulatory changes.
Counterpoint
If COO’s EPS beat is driven by mix/one-offs while organic revenue stays merely in-line, the stock could sell off despite headline EPS strength.
Key entities
- companyCooperCompanies
Subject of the article; reporting Q1 earnings after the bell with consensus revenue growth slowing to 5.1% YoY.
- companyBaxter
Peer read-across cited as delivering +2.9% YoY revenue growth and beating expectations.
- companyBoston Scientific
Peer read-across cited as delivering +11.6% revenue growth and topping estimates.
